arrow
J

Jill S. Barnholtz-Sloan

case comprehensive cancer center
H指数:128
被引数:13.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent genomic evolution in astrocytomas and oligodendrogliomas

星形胶质瘤和少突胶质瘤的基因组趋异进化

Nature
IF48.5
2026-10-140
OAAI
Solar ultraviolet radiation exposure, and incidence of childhood (0–19 years) malignant and non-malignant brain tumour in a US population-based dataset, 2000–2021

太阳紫外线辐射暴露与2000–2021年美国基于人群的数据库中0–19岁儿童恶性及非恶性脑瘤发病率

2025-11-240
OAAI
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma

基于DNA甲基化建模的头颅脑膜瘤临床管理框架

2025-11-190
OA
Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology

评估儿科、青少年和年轻成人脑膜瘤中的分子工具,强调了神经肿瘤学中需要全生命周期精确性

2025-11-080
OAAI
CHROMOSOME 1P LOSS AND 1Q GAIN ARE HIGHLY PROGNOSTIC AND CAN INFORM WHO GRADING OF MENINGIOMA

染色体1p缺失和1q获得是高度预测性的,并且可以用于指导脑膜瘤的WHO分级

2025-11-010
OAAI
TERT EXPRESSION IN MENINGIOMAS PREDICTS PROGRESSION-FREE SURVIVAL INDEPENDENT OF TERT PROMOTER MUTATION

TERT在脑膜瘤中的表达可独立于TERT启动子突变预测无进展生存期

2025-11-010
OAAI
Unveiling glioblastoma heterogeneity with deep learning derived MRI subtyping: insights from the global ReSPOND consortium

利用深度学习衍生MRI亚型对胶质母细胞瘤异质性进行解析:全球ReSPOND联盟的见解

2025-11-010
OAAI
Self-supervised multimodal learning for survival prediction in glioblastoma: a multicenter study from the ReSPOND consortium

用于胶质母细胞瘤生存预测的自监督多模态学习:来自ReSPOND联盟的多中心研究

2025-11-010
PRE
Determinants of geographic variation in the incidence of adult nonmalignant meningioma in the United States, 2010–2019

2010–2019年美国成人非恶性脑膜瘤发病率地理变异的决定因素

Cancer
IF5.1
2025-09-110
OAAI
Analysis of TERT association with clinical outcome in meningiomas: a multi-institutional cohort study

TERT与脑膜瘤临床结局关联性的分析:一项多中心队列研究

2025-09-010
PRE
53 DEVELOPMENT AND VALIDATION OF A MOLECULAR CLASSIFIER OF MENINGIOMAS

53 脑膜瘤分子分类器的开发与验证

2025-08-310
OAAI
17 CHROMOSOME 1P LOSS AND 1Q GAIN ARE HIGHLY PROGNOSTIC AND CAN INFORM WHO GRADING OF MENINGIOMA

17号染色体1p片段缺失和1q片段扩增是高度预测性的,并且可以用于指导脑膜瘤的WHO分级

2025-08-310
OAAI
17 CHROMOSOME 1P LOSS AND 1Q GAIN ARE HIGHLY PROGNOSTIC AND CAN INFORM WHO GRADING OF MENINGIOMA

17号染色体1p片段的缺失和1q片段的获得具有高度预后价值,并且能够为脑膜瘤的WHO分级提供信息。

2025-08-310
OAAI
33 TERT EXPRESSION PREDICTS PROGRESSION-FREE SURVIVAL IN MENINGIOMAS

33 TERT表达预测脑膜瘤的无进展生存期

2025-08-310
OA
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium

脑肿瘤液体活检方法中的前分析变量和检测物:RANO Group和Brain Liquid Biopsy Consortium的综述与建议

2025-08-010
PRE
Chromosome 1p Loss and 1q Gain for Grading of Meningioma

染色体1p缺失和1q增益在脑膜瘤分级中的应用

2025-04-030
PRE